Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

TRVN

Trevena (TRVN)

Trevena Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRVN
DataHoraFonteTítuloCódigoCompanhia
03/02/202518:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TRVNTrevena Inc
06/12/202418:39Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TRVNTrevena Inc
29/11/202409:05Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:TRVNTrevena Inc
07/11/202409:01GlobeNewswire Inc.Trevena Reports Third Quarter 2024 Results and Provides Business UpdateNASDAQ:TRVNTrevena Inc
04/10/202417:05GlobeNewswire Inc.Trevena Announces Receipt of Nasdaq Delisting NotificationNASDAQ:TRVNTrevena Inc
19/09/202417:09Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TRVNTrevena Inc
17/09/202419:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TRVNTrevena Inc
08/08/202417:05GlobeNewswire Inc.Trevena Announces Reverse Stock SplitNASDAQ:TRVNTrevena Inc
08/08/202408:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TRVNTrevena Inc
08/08/202408:00GlobeNewswire Inc.Trevena Reports Second Quarter 2024 Results and Provides Business UpdateNASDAQ:TRVNTrevena Inc
08/07/202410:15GlobeNewswire Inc.Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty FinancingNASDAQ:TRVNTrevena Inc
20/06/202408:00GlobeNewswire Inc.Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy ModelsNASDAQ:TRVNTrevena Inc
17/05/202417:05Edgar (US Regulatory)Form DEFR14A - Revised definitive proxy soliciting materialsNASDAQ:TRVNTrevena Inc
20/02/202418:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TRVNTrevena Inc
14/02/202416:34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:TRVNTrevena Inc
09/02/202418:05Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:TRVNTrevena Inc
23/01/202418:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TRVNTrevena Inc
23/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TRVNTrevena Inc
19/01/202418:30Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:TRVNTrevena Inc
10/01/202418:30Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TRVNTrevena Inc
06/09/202316:55AllPennyStocks.comBiotech Shares Are Running Again!NASDAQ:TRVNTrevena Inc
17/07/202318:29Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:TRVNTrevena Inc
17/07/202318:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TRVNTrevena Inc
06/07/202318:14Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TRVNTrevena Inc
30/06/202317:16Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TRVNTrevena Inc
28/06/202317:18Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TRVNTrevena Inc
26/06/202308:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TRVNTrevena Inc
09/05/202308:10Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:TRVNTrevena Inc
30/03/202308:18Edgar (US Regulatory)Annual Report (10-k)NASDAQ:TRVNTrevena Inc
14/02/202315:40Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TRVNTrevena Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:TRVN